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Abstract
Cortico-limbic brain activity associated with anger may be susceptible to nicotine and, thus, may
contribute to smoking initiation and nicotine addiction. The purpose of the study was to identify
the brain regions that are most reactive to nicotine and show the greatest association with anger
task performance. Twenty adult nonsmokers (9 women, 11 men) participated in two laboratory
sessions to assess brain metabolism with fluoro deoxy-glucose Positron Emission Topography
(FDG-PET) in response to nicotine and placebo patches during an anger provocation task.
Outcome variables for the anger provocation task were reaction time, intensity and length of
retaliation. Reaction time was associated with nicotine-induced changes in the left thalamus. Length
of retaliation was associated with a functionally linked set of cortical and subcortical structures such
as right frontal lobe, right anterior cingulate (BA 24), right uncus, left parietal lobe, left BA 11, left
cingulate, left BA 25, left amygdala, left BA 30, left BA 38 and BA 9. These findings reveal the
underlying brain circuitry targeted by nicotine during anger provocation.
Findings
Cigarette smoking is a major public health problem, and
angry dispositions have been identified as an important
risk factor for smoking initiation and subsequent nicotine
dependence [1-4]. In particular, behavioral studies
revealed a smoking-anger linkage [5-8], but little is known
about the underlying brain circuitry subserving such link-
age.
Dysfunctional cortico-limbic brain activity associated
with anger may be normalized by nicotine [4]. Functional
imaging studies on regional brain activity in response to
nicotine and smoking have documented the involvement
of cortico-limbic structures such as the prefrontal cortex
(including the dorsolateral prefrontal cortex, inferior
frontal, medial frontal, and orbitofrontal gyri) [9-15], cin-
gulate [12-16], thalamus [11,13,15,17-19], and amygdala
[12,13,15,19]. Similarly, anger has been associated with
activation of the medial prefrontal cortex, orbitofrontal
cortex, and anterior cingulate cortex [20-22]. However, lit-
tle is known about which brain areas are most responsive
to the effects of nicotine during anger provocation. The
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elevated risk of dependence and the greater difficulty quit-
ting may result, in part, from nicotine-associated normal-
ization of activity of cortico-limbic circuitry [4].
The cortico-limbic circuitry is part of the "prefrontal sys-
tem", which was first described by Rosvold and Schwatz-
bart [23] (see also review by Divac [24]) and may be
particularly sensitive to nicotine modulation. The objec-
tive of the present study was to identify the brain regions
within the prefrontal system that are most reactive to the
effects of nicotine and show the greatest association with
anger task performance in nonsmokers. Nonsmokers were
studied to determine the effects of a fixed low-dose of nic-
otine via patch without the confounding effects of smok-
ing and nicotine withdrawal. It was hypothesized that
nicotine-induced anger task performance is associated
with nicotine-induced changes in the medial prefrontal
cortex, orbitofrontal cortex, and anterior cingulate cortex.
Twenty adult nonsmokers (9 women, 11 men), with a
mean age of 24 (SD = 6), were recruited from the commu-
nity via ads and flyers. All participants were physically and
mentally healthy based on medical history obtained by a
physician (JM). Similar to previous research [25], non-
smokers were defined by self-reported smoking absti-
nence of at least 2 years prior to participation in the study
and not having smoked more than 100 cigarettes in their
lifetime. All participants provided written informed con-
sent approved by the Institutional Review Board of the
University of California, Irvine.
Each participant completed two laboratory sessions in
randomized order: one with a 3.5 mg low-dose transder-
mal nicotine patch (Nicoderm; GlaxoSmithKline) and the
other with a look-alike placebo patch. A 3.5 mg nicotine
patch (ie, 7 mg patch cut in half) was used to minimize
potential side-effects in nonsmokers. The two laboratory
sessions examined the acute effects of nicotine compared
to placebo on brain metabolism using fluoro deoxy-glu-
cose Positron Emission Topography (FDG-PET) during an
anger provocation task [26]. The anger provocation task
was a computerized Competitive Reaction Time task
(CRT) designed to induce and measure retaliatory tenden-
cies. Each participant competed with an ostensible "oppo-
nent" (of the same sex) to respond to a visual stimulus (ie,
red square) as quickly as possible. We enhanced the sali-
ency of the "opponent" by incorporating a video clip of
this person. The participant was asked to set the level of
white noise (0–105 dB) she/he wanted the opponent to
receive if the opponent lost. After the participant set the
noise level, a yellow square appeared as a "get ready" cue,
followed by the red square. The objective was to press a
mouse button as fast as possible. A scale on the left side of
the monitor indicated the noise level the opponent set for
the participant to receive. Provocation was manipulated
by increasing the noise level presumably set by the oppo-
nent across time. There were 25 trials, with white noise
presented during approximately 50% of the trials. The
noise blasts were delivered through headphones for a var-
iable length of time (set by the participant from trial to
trial). Output variables were average reaction time, inten-
sity, and length of retaliation.
Regions of interest were identified and verified with the
Talairach and Tournoux atlas [27] and included areas that
are associated primarily with the prefrontal system [24].
These areas cut across prefrontal, temporal and limbic
regions (see Table 1).
Each laboratory session lasted approximately 4.5 hours.
First, the patch was worn for 3 hours. Then an intravenous
injection of 5 mCi of FDG was given during the 30-minute
CRT. Subsequently, the subject lay in the scanner for 1
hour (see Fallon et al. [25] for more details). Patch admin-
istration was verified by serum cotinine levels (see Table
2).
For the PET data, normalized metabolic averages per ana-
tomical region per subject were used. The metabolic aver-
ages were rescaled in order to reduce inter-individual
variability in brain metabolism, and the resulting abso-
lute metabolic averages per anatomical region per subject
were used. Rescaling was achieved by taking the mean of
all the brain regions within a subject (ie, global mean)
and scaling it to the canonical normal global cerebral
blood flow (50 ml/min/dl). This is a common technique
used when analyzing PET data and provides some protec-
tion against false positives from global cerebral blood
Table 1: Regions of Interest
Frontal lobe
Superior frontal gyrus
Middle and medial frontal gyrus
Brodmann areas 9, 11, 24, 25, 29, 30, 32, 38, 46
Whole cingulate and anterior cingulate gyrus
Orbital gyrus
Parietal and temporal lobes
Limbic lobes
Amygdala
Hippocampus
Hypothalamus
Medial dorsal thalamic nucleus
Rectal gyrus
Subcallosal gyrus
Thalamus
Uncus
Substantia nigra-ventral tegmental area (SN-VTA)
Parahippocampus
Insula
Regions of interest were examined independently for left and right 
hemisphere activityBehavioral and Brain Functions 2009, 5:19 http://www.behavioralandbrainfunctions.com/content/5/1/19
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flow changes under a treatment condition [25,28]. Pre-
liminary analyses using t-tests revealed that BA 11 and
right rectal gyrus metabolism was significantly reduced
under nicotine compared to placebo patches, whereas BA
29 showed the opposite pattern (see Table 2). No other
significant differences were found [see Additional file 1].
For the anger provocation task, the CRT outcome meas-
ures of reaction time, intensity and length of retaliation
were averaged across the duration of the task. No signifi-
cant mean differences were found in anger task perform-
ance between nicotine and placebo conditions, perhaps
due to the low-dose nicotine patch (see Table 2). Group
means, however, do not reflect individual differences in
brain metabolism in response to nicotine. Therefore, step-
wise linear regression models were used to examine delta
scores for each outcome variable in order to contrast nic-
otine with placebo conditions (nicotine – placebo patch).
Stepwise linear regression models (SPSS 13.0) examined
which areas of the prefrontal system under nicotine com-
pared to placebo predicted CRT outcome variables in
response to nicotine versus placebo. Dependent variables
were the total scores on CRT outcome variables. Predictor
variables were the regions of interest. The inclusion crite-
rion used in each regression model was a probability
value of 0.05. The exclusion criterion was a probability
value of 0.06. To adjust for the number of brain regions,
alpha was Bonferroni-corrected at 0.0008.
Table 3: Stepwise linear regression for reaction time and length of retaliation
Dependent Variable Predictorsa Beta t P< R2 Collinearityb
Reaction Time Left Thalamus -0.750 4.538 0.0001 0.563 1.000
Length of Retaliation
Left Cingulate Gyrus -0.599 39.660 0.0001 1.000 1.218
Right Uncus 1.068 107.318 0.0001 1.649
Left Amygdala -0.349 43.520 0.0001 1.906
Left BA 9 0.679 56.707 0.0001 2.241
Right Frontal Lobe -0.635 45.924 0.0001 2.950
Right BA 24 0.245 19.426 0.0001 3.281
Left BA 30 -0.319 27.823 0.0001 3.479
Left Parietal Lobe 0.471 34.911 0.0001 4.269
Left BA 25 0.330 19.769 0.0001 5.069
Right BA 9 0.238 16.405 0.0001 5.805
Left BA 11 0.190 10.866 0.0001 9.191
Left BA 38 -0.099 8.167 0.0001 10.802
a The order of the predictors reflects the order of the stepwise linear regression
b Condition Index (i.e., values above 15 may indicate possible collinearity problems)
Table 2: Changes between nicotine versus placebo conditions in response to anger provocation
Variables Placebo
Mean (SD)
Nicotine
Mean (SD)
t(19) P≤
Cotinine Levelsa
Before patch 0.00 (0.00) 0.00 (0.00) N/A N/A
After patch 0.00 (0.00) 18.79 (24.20) 4.02 0.001
Region of Interestb
Left BA 11 410.78 (66.19) 386.20 (68.04) 2.26 0.036
Right BA 11 406.76 (68.57) 381.19 (73.84) 2.60 0.018
Right BA 29 482.28 (63.03) 503.19 (65.90) 2.31 0.032
Right Rectal Gyrus 424.02 (65.31) 388.98 (92.56) 2.46 0.024
CRT
Reaction timec 284.57 (70.78) 281.52 (77.02) 0.17 NS
Intensity of Retaliationb 5.53 (2.03) 5.59 (2.16) 0.13 NS
Length of Retaliationc 290.50 (213. 91) 319.92 (241.93) 0.82 NS
a in ng/ml
b in arbitrary units
c in msBehavioral and Brain Functions 2009, 5:19 http://www.behavioralandbrainfunctions.com/content/5/1/19
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The results from the regression models revealed that par-
ticipants who showed nicotine-induced changes in anger
task performance also showed changes in brain metabo-
lism. More specifically, nicotine-induced improvements
in reaction time were associated with decreased brain
metabolism in response to nicotine in the left thalamus.
This area of the brain explained 56% of variance for reac-
tion time (R = 0.75, R2 = 0.56, F change (1, 16) = 20.59, p
< 0.0001).
Nicotine-induced reductions in length of retaliation were
associated with increased brain metabolism in response
to nicotine in the left cingulate, left amygdala, right fron-
tal lobe, left BA 30, and left BA 38. In particular, the amy-
gdala has been shown to modulate prefrontal regional
activity [29]. However, our subjects included both women
and men so that some underlying amygdaloid contribu-
tion may have been diluted by mixed lateralization com-
ponents in women and men [30,31]. Positive associations
were found between nicotine-induced reductions in
length of retaliation and nicotine-induced reduction in
brain metabolism in the orbital-frontal areas (ie, right
uncus, left BA 9, right anterior cingulate (BA 24), left BA
25, right BA 9, and left BA 11) and left parietal lobe. These
predictors explained 100% of the variability in length of
retaliation (R = 1.00, R2 = 1.00, F change (1, 5) = 66.69, p
< 0.0001). No significant associations were found for
intensity of retaliation. See Table 3 for more details.
The involvement of generalized cortical and subcortical
areas may imply that nicotine-induced changes in anger
task performance correlate with nicotine-induced changes
in higher cortical and subcortical functioning responsible
for orienting, planning, and processing of emotional stim-
uli. Our findings identify a circuitry (see Figure 1), that is
primarily involved in the processing of emotional stimuli
[29,32-41] and complex adaptive, motivated behaviors,
including the regulation of emotion [20,22,42-46].
The present findings on nicotine-induced brain metabo-
lism in nonsmokers emphasize the role of negative affect,
particularly anger, in susceptibility to nicotine. Moreover,
Mid-sagittal drawing of cortical-limbic brain circuitry associated with anger provocation Figure 1
Mid-sagittal drawing of cortical-limbic brain circuitry associated with anger provocation. Blue areas indicate 
decreased nicotine-induced brain metabolism associated with increased nicotine-induced task performance. Red areas indicate 
increased nicotine-induced brain metabolism associated with increased nicotine-induced task performance. Lines represent 
implied circuitry based on well-documented anatomical connectivity. F = frontal lobe; P = parietal lobe
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the findings suggest that nicotine may critically regulate
brain areas that are involved in the inhibition of negative
emotions such as anger [43]. Deficits in anger manage-
ment may be a risk factor for smoking initiation and nic-
otine addiction, which may highlight the importance of
improving affect regulation as a potential smoking pre-
vention and cessation strategy [4]. Novel neurotherapeu-
tic and behavioral treatments (e.g., anger management
training) that affect the cortical and limbic brain areas
may aid smoking cessation efforts in anger provoking sit-
uations that increase withdrawal and tobacco cravings.
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